147 related articles for article (PubMed ID: 38261121)
1. Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation.
Kanchrana M; Gamidi RK; Kumari J; Sriram D; Basavoju S
Mol Divers; 2024 Jan; ():. PubMed ID: 38261121
[TBL] [Abstract][Full Text] [Related]
2.
Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology.
Allaka BS; Basavoju S; Madhu Rekha E; Sriram D; Rama Krishna G
Mol Divers; 2023 Jun; 27(3):1427-1436. PubMed ID: 35933454
[TBL] [Abstract][Full Text] [Related]
4. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and characterization of ethyl 3-benzoyl-7-morpholinoindolizine-1-carboxylate as anti-tubercular agents: In silico screening for possible target identification.
Tiwari P; Mangubhai GS; Kidwai S; Singh R; Chandrashekharappa S
Chem Biol Drug Des; 2024 Apr; 103(4):e14512. PubMed ID: 38570316
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
[TBL] [Abstract][Full Text] [Related]
7. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-
Venugopala KN; Uppar V; Chandrashekharappa S; Abdallah HH; Pillay M; Deb PK; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Tratrat C; Yousef Jaber A; Venugopala R; Mailavaram RP; Al-Jaidi BA; Kandeel M; Haroun M; Padmashali B
Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32392709
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents.
Atmaram Upare A; Gadekar PK; Sivaramakrishnan H; Naik N; Khedkar VM; Sarkar D; Choudhari A; Mohana Roopan S
Bioorg Chem; 2019 May; 86():507-512. PubMed ID: 30776681
[TBL] [Abstract][Full Text] [Related]
10. One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents.
Munnaluri RK; Chevula J; Patnam N; Yamini L; Manga V
Indian J Tuberc; 2023 Oct; 70(4):451-459. PubMed ID: 37968051
[TBL] [Abstract][Full Text] [Related]
11. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA
Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549
[TBL] [Abstract][Full Text] [Related]
12. A Green one-pot three component synthesis of thiazolidine-2,4-dione based bisspirooxindolo-pyrrolidines with [Bmim]BF
Rukyanaik V; Gamidi RK; Kumari J; Sriram D; Basavoju S
Mol Divers; 2024 May; ():. PubMed ID: 38789853
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures.
Nyoni NTP; Ncube NB; Kubheka MX; Mkhwanazi NP; Senzani S; Singh T; Tukulula M
Bioorg Chem; 2023 Dec; 141():106904. PubMed ID: 37832224
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of quinoxaline bearing tetrahydropyridine derivatives as anticancer, antioxidant, and anti-tubercular agents.
Pavale G; Acharya P; Korgavkar N; Ramana MMV
Curr Comput Aided Drug Des; 2022 Aug; ():. PubMed ID: 35927819
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Molecular Docking, and
Bhosale D; Mali SN; Thorat BR; Wavhal SS; Bhagat DS; Borade RM
Recent Adv Antiinfect Drug Discov; 2022; 17(1):69-83. PubMed ID: 35642111
[TBL] [Abstract][Full Text] [Related]
18. Microwave-assisted organic synthesis, antimycobacterial activity, structure-activity relationship and molecular docking studies of some novel indole-oxadiazole hybrids.
Desai NC; Somani HC; Mehta HK; Jadeja DJ; Khasiya AG; Khedkar VM
SAR QSAR Environ Res; 2022 Feb; 33(2):89-109. PubMed ID: 35102805
[TBL] [Abstract][Full Text] [Related]
19. Design and Synthesis of Quinazolinone-Triazole Hybrids as Potent Anti-Tubercular Agents.
Dutta A; Trivedi P; Gehlot PS; Gogoi D; Hazarika R; Chetia P; Kumar A; Chaliha AK; Chaturvedi V; Sarma D
ACS Appl Bio Mater; 2022 Sep; ():. PubMed ID: 36053225
[TBL] [Abstract][Full Text] [Related]
20. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
